ASTHMA
Clinical trials for ASTHMA explained in plain language.
Never miss a new study
Get alerted when new ASTHMA trials appear
Sign up with your email to follow new studies for ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Asthma drug trial halted: hope for severe cases unfulfilled
Disease control TerminatedThis study tested an oral drug called dexpramipexole in 654 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce asthma attacks and improve lung function over 52 weeks. However, t…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
Asthma pill trial halted midway: what it means for patients
Disease control TerminatedThis study tested a daily pill called dexpramipexole for people with severe eosinophilic asthma that was not well controlled by standard inhalers. The goal was to see if the drug could reduce serious asthma attacks over one year. The trial was stopped early, so results are limite…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Inhaled Mucus-Targeting drug tested for asthma and COPD – study halted early
Disease control TerminatedThis study tested an inhaled drug called ARO-MUC5AC in healthy people and those with moderate-to-severe asthma or COPD. The goal was to see if it is safe and how the body processes it. The study was stopped early, so results are limited. About 78 people were planned to take part.
Matched conditions: ASTHMA
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New asthma drug shows promise in early trial
Disease control TerminatedThis study tested an experimental drug called RPT193 in 38 adults with moderate-to-severe asthma that was not fully controlled by their usual inhalers. The goal was to see if the drug could prevent asthma attacks and improve lung function. The study was stopped early, so results …
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: RAPT Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Asthma pill for kids shows promise, but study halted early
Symptom relief TerminatedThis study looked at how a new chewable asthma tablet called fevipiprant works in children aged 6 to 12. The goal was to find the right dose and check for side effects. Only 11 children took part, and the study was stopped early, so results are limited.
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 17, 2026 03:13 UTC
-
Asthma mucus treatment study ends early with only 4 volunteers
Symptom relief TerminatedThis study looked at whether a 20% N-acetylcysteine (NAC) solution could improve lung function and reduce mucus in people with moderate-to-severe asthma. Only 4 participants were enrolled before the study was terminated. Each person received both NAC and a placebo in two-week per…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC
-
Scientists probe hidden causes of asthma Flare-Ups
Knowledge-focused TerminatedThis study looked at what causes sudden, severe asthma attacks in adults aged 18 to 75. Researchers measured mucus thickness in patients having an asthma attack to better understand the disease and how inhaled steroids help. The goal was to find new ways to treat asthma, but the …
Matched conditions: ASTHMA
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
New CT tools aim to spot steroid bone damage early
Knowledge-focused TerminatedThis study tested whether advanced CT scans can detect changes in bone density and marrow fat in people with asthma who take oral steroids. Researchers planned to compare steroid users to a control group. Only 2 people enrolled before the study was stopped, so results are very li…
Matched conditions: ASTHMA
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Gene clue to why some Kids' asthma inhalers work better
Knowledge-focused TerminatedThis study looked at whether a specific gene (PDE4) affects how well children with asthma respond to the rescue inhaler salbutamol. Researchers planned to compare lung function changes in 99 children aged 6-18 based on their gene type. The study was terminated early, so results a…
Matched conditions: ASTHMA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC
-
Preterm Tots' lungs under the microscope: new study aims to uncover asthma clues
Knowledge-focused TerminatedThis study followed 152 preschool children (ages 3-5) to see how being born early (before 37 weeks) affects lung function. Researchers measured breathing using special tests and checked for allergies. The goal was to learn more about asthma and allergic rhinitis risks in preterm …
Matched conditions: ASTHMA
Sponsor: Stefania La Grutta, MD • Aim: Knowledge-focused
Last updated May 04, 2026 16:21 UTC